AEON Biopharma, Inc. (AEON) stock
AEONNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.15−0.01 (-3.59%)
Close on Nov 13, 2026Market cap $7.63MP/E –Yield –
AEON Biopharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
AEON Biopharma's enterprise value was $1.08M on Nov 11, 2026, against $3.94M a year earlier. Over the last 4 years it ranged from -$4.38M to $1.45B, with a median of $8.17M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.08M | -84.3% |
| 2025 | Dec 31, 2025 | $6.88M | -67.0% |
| 2024 | Dec 31, 2024 | $20.84M | -91.7% |
| 2023 | Dec 29, 2023 | $251.35M | – |
See a number that looks wrong?